《[医药]李氏大业厂控股有限公司》由会员分享，可在线阅读，更多相关《[医药]李氏大业厂控股有限公司（2页珍藏版）》请在金锄头文库上搜索。
1、 1 The Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibilities for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or
2、 in reliance upon the whole or any part of the contents of this announcement. LEES PHARMACEUTICAL HOLDINGS LIMITED 李氏大藥廠控股有限公司李氏大藥廠控股有限公司李氏大藥廠控股有限公司李氏大藥廠控股有限公司* (incorporated in the Cayman Islands with limited liability) (Stock Code : 950) GRANT OF SHARE OPTIONS This announcement is made pursuant to
3、 Rule17.06A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. The board of directors of Lees Pharmaceutical Holdings Limited (the “Company”) hereby announces that on 7 October 2011, 469,000 share options (the “Share Options”) to subscribe for ordinary share
4、s of HK$0.05 each (the “Shares”) of the Company were granted under the Rules of the Share Option Scheme approved by the written resolution of all shareholders of the Company passed on 26 June 2002: Date of grant 7 October 2011 Exercise price of Share Options granted HK$2.526 per Share Number of Shar
5、e Options granted 469,000 Closing price of the Shares on the date of grant HK$2.48 per Share Details of grantees Director Number of Share Options Leelalertsuphakun Wanee 469,000 Validity period of the Share Options The options will, in respect of not more than 50% thereof, be exercisable not less th
6、an six months but not more than ten years from the date of grant, i.e. during the period from 7 April 2012 to 6 October 2021 (both days inclusive), and in respect of the unexercised balance thereof, be exercisable not less than fifteen months but not more than ten years from the date of grant, i.e.
7、during the period from 7 January 2013 to 6 October 2021 (both days inclusive) 2 By Order of the Board Lees Pharmaceutical Holdings Limited Lee Siu Fong Chairman Hong Kong, 7 October 2011 * For identification purpose only As at the date of this announcement, Ms. Lee Siu Fong, Ms. Leelalertsuphakun Wanee and Dr. Li Xiaoyi are executive Directors; Mr. Mauro Bove is non-executive Director; Dr. Chan Yau Ching, Bob, Mr. Lam Yat Cheong and Dr. Tsim Wah Keung, Karl are independent non-executive Directors.
